WINT - Windtree TherapeuticS GAAP EPS of -$0.13 beats by $0.13
- Windtree TherapeuticS press release ( NASDAQ: WINT ): Q3 GAAP EPS of -$0.13 beats by $0.13 .
- As of September 30, 2022, the Company reported cash and cash equivalents of $8.4 million, which is expected to be sufficient to fund operations into the second quarter of 2023.
For further details see:
Windtree TherapeuticS GAAP EPS of -$0.13 beats by $0.13